Æterna Zentaris, Inc.
(Toronto Stock Exchange : AEZS)

( )
AEZS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.83%169.390.0%$1421.93m
AMGNAmgen, Inc. -0.59%254.211.3%$686.16m
NVAXNovavax, Inc. -1.73%223.4180.0%$644.21m
SNSSSunesis Pharmaceuticals, Inc. 0.00%8.000.7%$559.23m
ILMNIllumina, Inc. 0.00%399.003.5%$519.65m
GILDGilead Sciences, Inc. -0.06%66.831.0%$470.22m
REGNRegeneron Pharmaceuticals, Inc. -0.12%502.002.7%$458.19m
VRTXVertex Pharmaceuticals, Inc. 0.28%220.001.9%$389.68m
ALXNAlexion Pharmaceuticals, Inc. 0.48%164.472.0%$349.78m
BNTXBioNTech SE 0.29%151.980.0%$314.48m
BIIBBiogen, Inc. 0.00%270.311.7%$263.29m
EXASEXACT Sciences Corp. -1.99%127.4518.4%$182.48m
NBIXNeurocrine Biosciences, Inc. 0.79%97.344.9%$181.15m
CRSPCRISPR Therapeutics AG -0.09%118.450.6%$166.42m
SGENSeagen Inc. 0.00%145.505.8%$146.84m

Company Profile

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.